Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding

BACKGROUND: Recombinant gp120 (MN-rgp120) was a major component of the AIDSVAX B/E vaccine used in the RV144 trial. This was the first clinical trial to show that vaccination could prevent HIV infection in humans. A recent RV144 correlates of protection study found that protection correlated with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Gerald R., Fonseca, Dora P. A. J., O'Rourke, Sara M., Vollrath, Aaron L., Berman, Phillip W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374778/
https://www.ncbi.nlm.nih.gov/pubmed/22720026
http://dx.doi.org/10.1371/journal.pone.0039045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374778/
https://www.ncbi.nlm.nih.gov/pubmed/22720026
http://dx.doi.org/10.1371/journal.pone.0039045

Ejemplares similares